featured image

Samsung , NeuroLogica , IDN , GPO , corporate accounts

Samsung Continues to Invest in Serving and Growing its Corporate Accounts Business Base


June 7, 2017  DANVERS, Mass.--()--Samsung, a leader in medical imaging technology, is enhancing its commitment to serve more Integrated Delivery Networks (IDNs) and Group Purchasing Organizations (GPOs) across the country with its suite of innovative medical imaging solutions that deliver the best patient outcomes and experiences at the lowest cost.

“Samsung has a great history of delivering innovative products that have the highest customer value. That philosophy of value excellence is well aligned with a corporate account organization’s goal of ensuring maximum value to their members,” said Philip Sullivan, Samsung, NeuroLogica Division, President and CEO.

Samsung’s suite of innovative imaging products delivers the sharpest picture through an intuitive design that enhances the patient and clinician experience, all at an affordable price point. To get this message out to the market, Sullivan recently promoted David Legg, an executive with more than 25 years of experience working with IDNs and GPOs, to Vice President, Corporate Accounts.

“David’s promotion is a sign of our commitment to serve and grow our corporate accounts base,” said Sullivan. “He brings a wealth of experience to the role and will provide healthcare systems with innovative, cost-effective imaging solutions for their hospitals and patients.”

Legg heads up a growing team focused on expanding Samsung’s corporate accounts business, which has already made great accomplishments, signing large-volume contracts with some of the largest commercial and government customers in the country.

“Our philosophy of delivering innovative products that offer the absolute best patient and clinician experience at the lowest possible cost aligns perfectly with the goals of GPOs and IDNs, who are trying to do the same thing,” said Legg. “Samsung’s well-established brand is already associated with innovation, and our healthcare products are no different.”

About Samsung NeuroLogica
Samsung NeuroLogica, the healthcare subsidiary of Samsung Electronics Co., Ltd., develops, manufactures, and markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. Samsung NeuroLogica, the global corporate headquarters and manufacturer of Samsung computed tomography, is also the US headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. Samsung NeuroLogica’s growing portfolio of advanced medical technologies are used worldwide in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency. Samsung is committed to being leaders in the field of healthcare imaging. For more information, please visit

Click here to view source version on

Samsung NeuroLogica
Lynne Gagne, 978-564-8576

Recent Press

New Call-to-action

Connect With Us